In Dr. William Carson’s experience, he says, “It is as difficult today to get African Americans to participate in clinical trials as it was 20 years ago.” Why is that? Many of us are fearful about clinical trials, recalling the Tuskegee Experiment and others. Or, we are uninformed about what really happens during participation in a clinical trial. In this “CEO Spotlight” segment, Dr. Carson, CEO of Otsuka, shares his insights on why more African Americans should participate in clinical trials. Watch the full interview with Dr. Carson here.
by Team BlackDoctor.org
The Latest In Clinical Trials
Clinical trials are research studies that use human volunteers to determine whether a medical strategy, treatment, or device is safe for people to use. Clinical trials aim to increase medical knowledge about disease treatment, diagnosis, and prevention through research. Clinical read more about Clinical Trials: Everything you Need to Know
Over the past few months, we have learned more about how COVID-19 is affecting populations around the world. Since the initial cases in this country were reported in February, it is apparent that there is a disproportionate impact on members read more about How “You” Can Change the Future of Healthcare!
Facts are facts! Without higher levels of participation among African Americans, we will never unlock the root causes of the disparate impact of illnesses, diseases, and ailments plaguing black communities today. Every day that African Americans continue to live in read more about Should Black Americans Still Be Leary of Clinical Trials?
Research has shown that cancer patients in rural areas have lower survival rates than those in urban areas. For example, cancer death rates between 2011 and 2015 were 180 per 100,000 people in rural areas and 158 per 100,000 people read more about Your Cancer Survival Rate May Be A Matter of Participating in Clinical Trials, or Not
Click HERE For More Information
As most of you are aware, the treatment of HIV requires multiple drugs. Since the mid-nineties, the rule has been to use three drugs to control HIV, but sometimes that wasn’t possible if the patient was resistant to drugs read more about How Low Can We Go? A Clinical Trial Gives Hope For New HIV Drug Options